EP3439637
PROCESS FOR MESALAZINE SOLID FORMULATIONS
Hover an owner to see their dates
- Alfasigma s.p.a.since Apr 28, 2023
- SOFAR S.p.A.Jan 11, 2019 – Apr 28, 2023
The present invention relates to a process to prepare solid pharmaceutical forms comprising a quantity of mesalazine comprised between 75 and 95%, i.e. between 1000 and 1600 mg of drug per dosage unit. Furthermore, the present invention relates to a granulate and/or tablets obtained/obtainable with the process according to the invention, preferably coated to allow the controlled release of the drug. Finally, the present invention relates to the use of the granulate and/or the tablets as a medicament, preferably for the treatment of chronic inflammatory pathologies that preferably affect the intestinal tract.
From the international application WO2017175123
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| May 29, 2026 | UPC CFI 1920/2026 | Milan LD | Provisional measures | Locked | Alfasigma s.p.a. +2 |
Additional proceedings on this patent